Daan Gene Co Ltd Class A 002030
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥5.84
- Day Range
- ¥6.01–6.42
- 52-Week Range
- ¥4.71–11.00
- Bid/Ask
- ¥6.42 / ¥0.00
- Market Cap
- ¥9.01 Bil
- Volume/Avg
- 61.4 Mil / 30.8 Mil
Key Statistics
- Price/Earnings (Normalized)
- 12.70
- Price/Sales
- 8.73
- Dividend Yield (Trailing)
- 0.23%
- Dividend Yield (Forward)
- 0.23%
- Total Yield
- 0.23%
Company Profile
Daan Gene Co Ltd is a high-tech enterprise-oriented in molecular diagnostic techniques. It is primarily committed to research and development, production, and service of in-vitro diagnostic products, including qPCR, Sequeacing, TRF, ELISA, and Liquid-Based Cytology diagnostic kits and equipment. Geographically, tahe group operates in China.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Mid Value
- Total Number of Employees
- 1,968
- Website
- https://www.daangene.com
Comparables
Valuation
Metric
|
002030
|
688468
|
688253
|
---|---|---|---|
Price/Earnings (Normalized) | 12.70 | 21.05 | 21.74 |
Price/Book Value | 1.07 | 2.05 | 3.00 |
Price/Sales | 8.73 | 6.16 | 8.86 |
Price/Cash Flow | 15.08 | 14.42 | 17.00 |
Price/Earnings
002030
688468
688253
Financial Strength
Metric
|
002030
|
688468
|
688253
|
---|---|---|---|
Quick Ratio | 2.15 | 4.71 | 15.40 |
Current Ratio | 4.15 | 5.48 | 15.84 |
Interest Coverage | −78.04 | 111.54 | 2,238.82 |
Quick Ratio
002030
688468
688253
Profitability
Metric
|
002030
|
688468
|
688253
|
---|---|---|---|
Return on Assets (Normalized) | −5.89% | 7.46% | 12.17% |
Return on Equity (Normalized) | −7.30% | 9.59% | 13.13% |
Return on Invested Capital (Normalized) | −7.42% | 7.98% | 12.68% |
Return on Assets
002030
688468
688253
Biotechnology Industry Comparables
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|---|
Novo Nordisk AS ADR
NVO
| Qglnphvtsf | Ptfdc | $512.4 Bil | |||
Vertex Pharmaceuticals Inc
VRTX
| Hqwmdzqc | Wrrwyw | $117.5 Bil | |||
Regeneron Pharmaceuticals Inc
REGN
| Mwhwfqb | Cmxjxyy | $111.6 Bil | |||
Alnylam Pharmaceuticals Inc
ALNY
| Dmxwvzpcx | Vdnwcxk | $34.4 Bil | |||
argenx SE ADR
ARGX
| Chdhmvyvn | Klp | $31.7 Bil | |||
BioNTech SE ADR
BNTX
| Vwhwjptwm | Sswkg | $29.2 Bil | |||
Moderna Inc
MRNA
| Zcpgqdzx | Ydlt | $23.1 Bil | |||
United Therapeutics Corp
UTHR
| Xgstwpkt | Fym | $15.8 Bil | |||
Biomarin Pharmaceutical Inc
BMRN
| Xcdcthgn | Bvyknc | $13.2 Bil | |||
Incyte Corp
INCY
| Dgzrdzgs | Vylhwl | $13.0 Bil |